Control of cell number in developing retina

视网膜发育中细胞数量的控制

基本信息

  • 批准号:
    7454267
  • 负责人:
  • 金额:
    $ 39.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-08-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Successful development of a functional eye requires not only cell-differentiation programs that specify various retina cell types, but also size-control mechanisms that determine the number of cells in the retina. My laboratory is taking molecular, genetic and biochemical approaches to understand the molecular mechanisms that specify retina cell number. Using the compound eye of Drosophila as an experimental model, my laboratory has recently identified a key signaling pathway that controls retina cell number by coordinately regulating cell proliferation and cell death. This pathway is defined by three tumor suppressor genes that normally negatively regulate retina cell number: hippo (hpo), salvador (sav) and warts (wts). Hpo, a Ser/Thr kinase, binds to and phosphorylates Sav, an adaptor protein containing WW and coiled-coil domains. Interactions between Hpo and Sav in turn potentiate the kinase activity of Hpo towards Wts. Inactivation of this pathway results in elevated transcription of the cell cycle regulator Cyclin E and the cell death inhibitor diap1, thus leading to increased proliferation and reduced apoptosis. Moreover, this pathway appears to play an evolutionarily conserved role in mammals. Here we propose three specific aims to further understand the function and regulation of the Hpo pathway in retina size-control. In the first specific aim, we will determine the molecular mechanisms by which the Hpo pathway regulates diap1 transcription by identifying the Hpo-responsive transcription factor and analyzing its mode of regulation. In the second specific aim, we will determine the cellular mechanism of the Hpo signal transduction pathway. In the third specific aim, we will use biochemical, yeast two-hybrid and genetic approaches to identify additional components of the Hpo pathway. Besides revealing basic mechanisms of eye development, our studies have general implications for the development of other tissues.
描述(由申请人提供):成功开发功能性眼睛不仅需要细胞分化程序,指定各种视网膜细胞类型,还需要大小控制机制,决定视网膜中细胞的数量。我的实验室正在采用分子、遗传和生化的方法来了解决定视网膜细胞数量的分子机制。我的实验室最近利用果蝇复眼作为实验模型,发现了一个通过协调调节细胞增殖和细胞死亡来控制视网膜细胞数量的关键信号通路。该途径由三种通常负调控视网膜细胞数量的肿瘤抑制基因定义:hippo (hpo)、salvador (sav)和warts (wts)。Hpo是一种丝氨酸/苏氨酸激酶,结合并磷酸化Sav, Sav是一种含有WW和卷曲结构域的接头蛋白。Hpo和Sav之间的相互作用反过来增强了Hpo对Wts的激酶活性。该通路的失活导致细胞周期调节因子Cyclin E和细胞死亡抑制剂diap1的转录升高,从而导致增殖增加和细胞凋亡减少。此外,这一途径似乎在哺乳动物中起着进化保守的作用。为了进一步了解Hpo通路在视网膜大小控制中的功能和调控,我们提出了三个具体目标。在第一个具体目标中,我们将通过鉴定Hpo应答转录因子并分析其调节模式来确定Hpo通路调节diap1转录的分子机制。在第二个具体目标中,我们将确定Hpo信号转导途径的细胞机制。在第三个具体目标中,我们将使用生化,酵母双杂交和遗传方法来确定Hpo途径的其他组成部分。除了揭示眼睛发育的基本机制外,我们的研究对其他组织的发育也有普遍的意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DUOJIA PAN其他文献

DUOJIA PAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DUOJIA PAN', 18)}}的其他基金

Chemical probes targeting nuclear effector complex of the Hippo signaling pathway
针对 Hippo 信号通路核效应复合物的化学探针
  • 批准号:
    9334003
  • 财政年份:
    2016
  • 资助金额:
    $ 39.02万
  • 项目类别:
Control of Cell Number in Developing Retina
视网膜发育中细胞数量的控制
  • 批准号:
    9127251
  • 财政年份:
    2016
  • 资助金额:
    $ 39.02万
  • 项目类别:
Control of Cell Number in Developing Retina
视网膜发育中细胞数量的控制
  • 批准号:
    9334004
  • 财政年份:
    2016
  • 资助金额:
    $ 39.02万
  • 项目类别:
Chemical probes targeting nuclear effector complex of the Hippo signaling pathway
针对 Hippo 信号通路核效应复合物的化学探针
  • 批准号:
    8629276
  • 财政年份:
    2014
  • 资助金额:
    $ 39.02万
  • 项目类别:
Chemical probes targeting nuclear effector complex of the Hippo signaling pathway
针对 Hippo 信号通路核效应复合物的化学探针
  • 批准号:
    8791311
  • 财政年份:
    2014
  • 资助金额:
    $ 39.02万
  • 项目类别:
Function of the Small GTPase Rheb in Cell Growth
小 GTP 酶 Rheb 在细胞生长中的功能
  • 批准号:
    7086362
  • 财政年份:
    2005
  • 资助金额:
    $ 39.02万
  • 项目类别:
Function of the Small GTPase Rheb in Cell Growth
小 GTP 酶 Rheb 在细胞生长中的功能
  • 批准号:
    6979847
  • 财政年份:
    2005
  • 资助金额:
    $ 39.02万
  • 项目类别:
Function of the Small GTPase Rheb in Cell Growth
小 GTP 酶 Rheb 在细胞生长中的功能
  • 批准号:
    7452291
  • 财政年份:
    2005
  • 资助金额:
    $ 39.02万
  • 项目类别:
Function of the Small GTPase Rheb in Cell Growth
小 GTP 酶 Rheb 在细胞生长中的功能
  • 批准号:
    7244421
  • 财政年份:
    2005
  • 资助金额:
    $ 39.02万
  • 项目类别:
Control of cell number in developing retina
视网膜发育中细胞数量的控制
  • 批准号:
    8509133
  • 财政年份:
    2004
  • 资助金额:
    $ 39.02万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.02万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.02万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.02万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.02万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.02万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.02万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.02万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.02万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.02万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.02万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了